Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i>
Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> have?
Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> has 5 citations in the OpenAlex counts ScholarIQ stores.
When was Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> published?
Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> has 2021 year in the ScholarIQ index.
What is the open-access status of Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i>?
Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> has closed oa status in the ScholarIQ index.
What is the DOI of Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i>?
The DOI for Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> is on the source record.
What is the PMID of Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i>?
The PMID for Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> is on the source record.
What is the OpenAlex record for Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i>?
The OpenAlex for Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i> is on the source record.